Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
2011

Curcumin's Effects on Medulloblastoma Growth

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lee Seung Joon, Krauthauser Candice, Maduskuie Victoria, Fawcett Paul T, Olson James M, Rajasekaran Sigrid A

Primary Institution: Nemours Center for Childhood Cancer Research

Hypothesis

Can curcumin induce apoptosis and inhibit tumor growth in medulloblastoma?

Conclusion

Curcumin has the potential to be developed as a therapeutic agent for medulloblastoma, as it induces apoptosis and reduces tumor growth.

Supporting Evidence

  • Curcumin induced apoptosis and cell cycle arrest in medulloblastoma cells.
  • Curcumin reduced tumor growth in medulloblastoma xenografts.
  • Curcumin increased survival in the Smo/Smo transgenic medulloblastoma mouse model.
  • Curcumin inhibited HDAC4 expression and activity.
  • Curcumin increased tubulin acetylation in medulloblastoma cells.

Takeaway

Curcumin, a spice, can help fight a type of brain cancer in kids by making the cancer cells die and stopping them from growing.

Methodology

The study used cultured medulloblastoma cells, tumor xenografts, and a transgenic mouse model to test curcumin's effects.

Limitations

The tumors were not completely eradicated, and the study did not explore all potential mechanisms of curcumin's action.

Participant Demographics

The study involved human medulloblastoma cell lines and transgenic mice.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-11-144

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication